Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant- Dominant Periods in Korea

被引:23
|
作者
Choi, Soo -Han [1 ]
Choi, Jae Hong [2 ]
Lee, Joon Kee [3 ]
Eun, Byung-Wook [4 ]
Ha Song, Seung [5 ]
Ahn, Bin [5 ]
Kim, Ye Kyung [5 ]
Yun, Ki Wook [5 ,6 ]
机构
[1] Pusan Natl Univ, Sch Med, Dept Pediat, Busan, South Korea
[2] Jeju Natl Univ, Sch Med, Dept Pediat, Jeju, South Korea
[3] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Coll Med, Dept Pediat, Cheongju, South Korea
[4] Nowon Eulji Univ Hosp, Dept Pediat, Seoul, South Korea
[5] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul, South Korea
[6] Seoul Natl Univ, Coll Med, Dept Pediat, 101 Daehak Ro, Seoul 03080, South Korea
关键词
COVID-19; SARS-CoV-2; Variants; SARS-CoV-2 Omicron Variant; SARS-CoV-2 Delta Variant; Child; Adolescent; LABORATORY-CONFIRMED COVID-19-COVID-NET; 14; STATES; HOSPITALIZATIONS; TRANSMISSION;
D O I
10.3346/jkms.2023.38.e65
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Data on the clinical characteristics of pediatric patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant infection are limited. We aimed to evaluate the clinical features and outcomes of children with SARS-CoV-2 infection before and after omicron variant dominance in Korea.Methods: A multicenter retrospective cohort study was conducted in hospitalized patients aged <= 18 years with laboratory-confirmed SARS-CoV-2 infection at five university hospitals in South Korea. The study periods were divided into the delta (from August 23, 2021 to January 2, 2022) and omicron (from January 30 to March 31, 2022).Results: In total, 612 hospitalized patients were identified (211, delta; 401, omicron). During the omicron and delta periods, the proportions of individuals with serious illness (moderate, severe, and critical severity) were 21.2% and 11.8%, respectively (P = 0.034). Compared with the delta period, the proportions of patients with moderate illness increased significantly in the age groups of 0-4 years (14.2% vs. 3.4%) and 5-11 years (18.6% vs. 4.2%) during the omicron period. During the two periods, the proportions of patients with complex chronic diseases (delta, 16.0% vs. 4.3%, P = 0.040; omicron, 27.1% vs. 12.7%; P = 0.002), respiratory diseases except for asthma (delta, 8.0% vs. 0.0%, P = 0.013; omicron, 9.4% vs. 1.6%; P = 0.001), and neurologic diseases (delta, 28.0% vs. 3.2%, P < 0.001; omicron, 40.0% vs. 5.1%, P < 0.001) were significantly higher in patients with serious illness than in those with non -serious illness. During the delta period, the risk for serious illness was higher among patients with obesity (adjusted odds ratio [aOR], 8.18; 95% confidence interval [CI], 2.80-27.36) and neurologic diseases (aOR, 39.43; 95% CI, 6.90-268.3) and aged 12-18 years (aOR, 3.92; 95% CI, 1.46-10.85). However, the presence of neurologic disease (aOR, 9.80; 95% CI, 4.50-22.57) was the only risk factor for serious illness during the omicron period. During the omicron period, the proportions of patients with croup (11.0% vs. 0.5%) and seizures (13.2% vs. 2.8%) increased significantly compared with the delta period.Conclusion: Compared with the delta period, the proportions of young children and patients with complex comorbidities were higher during the omicron period in Korea. Patients with complex chronic diseases, especially neurologic diseases, had a high risk of severe coronavirus disease 2019 in the two distinct variant-dominant periods.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] SARS-CoV-2 dual infection with Delta and Omicron variants in an
    Abroi, Aare
    Talas, Ulvi Gerst
    Pauskar, Merit
    Shablinskaja, Arina
    Reisberg, Tuuli
    Niglas, Heiki
    Pall, Taavi
    Nelis, Mari
    Tagen, Ingrid
    Soodla, Pilleriin
    Lutsar, Irja
    Huik, Kristi
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 124 : 41 - 44
  • [22] Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis
    Relan, Pryanka
    Motaze, Nkengafac Villyen
    Kothari, Kavita
    Askie, Lisa
    de Waroux, Olivier Le Polain
    Van Kerkhove, Maria D.
    Diaz, Janet
    Vijayaraghavan, Bharath Kumar Tirupakuzhi
    BMJ GLOBAL HEALTH, 2023, 8 (07):
  • [23] Superspreading potential of infection seeded by the SARS-CoV-2 Omicron BA.1 variant in South Korea
    Guo, Zihao
    Zhao, Shi
    Ryu, Sukhyun
    Mok, Chris Ka Pun
    Hung, Chi Tim
    Chong, Ka Chun
    Yeoh, Eng Kiong
    JOURNAL OF INFECTION, 2022, 85 (03) : E77 - E79
  • [24] SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant
    Taytard, Jessica
    Prevost, Blandine
    Schnuriger, Aurelie
    Aubertin, Guillaume
    Berdah, Laura
    Bitton, Lauren
    Dupond-Athenor, Audrey
    Thouvenin, Guillaume
    Nathan, Nadia
    Corvol, Harriet
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [25] Elder and booster vaccination associates with decreased risk of serious clinical outcomes in comparison of Omicron and Delta variant: A meta-analysis of SARS-CoV-2 infection
    Wu, Yanhua
    Pan, Yuchen
    Su, Kaisheng
    Zhang, Yangyu
    Jia, Zhifang
    Yi, Jiaxin
    Lv, Haiyong
    Zhang, Lihuan
    Xue, Mingyang
    Cao, Donghui
    Jiang, Jing
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [26] Spontaneous pneumomediastinum: A complication of SARS-CoV-2 variant delta infection in children
    Prevost, Blandine
    Leger, Pierre-Louis
    Sileo, Chiara
    Corvol, Fany
    Lecarpentier, Thibault
    Nathan, Nadia
    Corvol, Harriet
    PEDIATRIC PULMONOLOGY, 2024, 59 (05) : 1469 - 1472
  • [27] Epidemiological and clinical features of SARS-CoV-2 infection in children during the outbreak of Omicron variant in Shanghai, March 7-31, 2022
    Wang, Xiangshi
    Chang, Hailing
    Tian, He
    Zhu, Yanfeng
    Li, Jingjing
    Wei, Zhongqiu
    Wang, Yixue
    Xia, Aimei
    Ge, Yanling
    Liu, Gongbao
    Cai, Jiehao
    Zhu, Qirong
    Zhai, Xiaowen
    Zeng, Mei
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (06) : 1059 - 1065
  • [28] Increasing rates of sars-cov-2 infection in newborns during the omicron variant epoch
    Eid, Joe
    Post, Sara
    Guhde, Heather
    Basuray, Rakhi Gupta
    Sanchez, Pablo J.
    Costantine, Maged M.
    Rood, Kara M.
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2023, 90 (02)
  • [29] Transmission Dynamics of the Delta Variant of SARS-CoV-2 Infections in South Korea
    Hwang, Hari
    Lim, Jun-Sik
    Song, Sun-Ah
    Achangwa, Chiara
    Sim, Woobeom
    Kim, Giho
    Ryu, Sukhyun
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (05) : 793 - 799
  • [30] Delta and Omicron SARS-CoV-2 pneumonia: Comparison of clinical and radiological features
    Pehlivan, Jonathan
    Berge, Pierre
    Gourdier, Anne-Laurence
    Phelippeau, Michael
    Danneels, Pierre
    Mahieu, Rafael
    Dubee, Vincent
    INFECTIOUS DISEASES NOW, 2025, 55 (02):